What does "research-grade Epithalon" actually mean for an Australian buyer?
"Research-grade" is not a legally defined grade, so the term only means as much as the analytical file behind it. For a synthetic tetrapeptide like Epithalon (AEDG), the meaningful definition is: material whose identity, purity and content have been characterised by validated laboratory methods, with the results recorded on a lot-specific Certificate of Analysis. Epithalon is described in the literature as a short pineal-derived regulatory peptide (Araj et al., 2025), and its small four-residue sequence makes it comparatively straightforward to confirm by mass spectrometry, yet still susceptible to synthesis-related impurities such as truncated or deletion sequences. An Australian supplier should therefore be assessed on documentation rather than marketing language. When evaluating a vendor, confirm three things exist in writing before any purchase: (1) a stated theoretical monoisotopic and average mass for the AEDG sequence that the CoA can be checked against; (2) a chromatographic purity value with the method named; and (3) a lot or batch number that appears both on the CoA and on the vial label. A supplier that holds local Australian stock with tracked dispatch and per-lot documentation gives you traceability that generic overseas listings rarely match. The absence of a downloadable, lot-matched CoA is the single clearest signal to walk away. Because Epithalon is supplied for laboratory research only, none of this documentation implies any suitability for use in humans or animals — it exists purely so that an analyst can characterise and account for the material they receive, and reconcile it against their own incoming-goods testing. Treat the CoA as the contract of identity between you and the supplier.
How is Epithalon (AEDG) identity confirmed on a Certificate of Analysis?
Identity confirmation for a tetrapeptide relies on orthogonal methods — no single result is sufficient. The primary tool is mass spectrometry: electrospray ionisation (ESI-MS) or MALDI-TOF is used to measure the molecular mass and compare it against the theoretical value for Ala-Glu-Asp-Gly. For a short sequence, the observed mass should agree closely with the calculated value, and a competent CoA will state both. Where sequence-level confirmation is required, tandem mass spectrometry (MS/MS) fragments the molecule and maps the resulting product ions back to the expected residue order, distinguishing genuine AEDG from isobaric or transposed-sequence impurities. This matters because regulatory peptides of this class have been characterised in the research literature for their interaction with nucleic acids and transcription-level processes (Khavinson et al., 2003; Khavinson et al., 2005), which makes precise sequence identity — not just a matching mass — the property a rigorous analyst wants to verify. Reversed-phase HPLC retention time, compared against a qualified reference standard, provides a second independent identity checkpoint. When reviewing a supplier's documentation, look for: the ionisation technique named; the theoretical versus observed mass; whether MS/MS or only intact-mass data is provided; and whether an HPLC retention-time comparison to a reference is included. A CoA that shows only a purity percentage with no identity method has confirmed nothing about what the peptide actually is. For an Australian buyer, asking a supplier to specify which orthogonal methods underpin the identity claim is a fast, objective way to separate documented material from relabelled stock.
Which purity and impurity parameters should the CoA report?
Purity for synthetic peptides is normally expressed as area-percent by reversed-phase HPLC with UV detection, and the CoA should name the wavelength (commonly 214–220 nm for peptide bonds), the column chemistry and the gradient in enough detail that the result is reproducible. A bare "98% pure" figure with no method is not verifiable. Beyond the headline purity number, ask what the related-substances profile looks like: for a tetrapeptide the most common process impurities are truncated sequences, deletion peptides and, for glutamate/aspartate-containing peptides like AEDG, deamidation-related species. A thorough impurity assessment pairs HPLC with LC-MS so that each significant peak can be assigned a mass and, ideally, an identity rather than being logged as an anonymous "unknown". Peak purity assessment using a diode-array detector (DAD) adds confidence that the main peak is a single component and not two co-eluting species — a relevant consideration given how frequently "peak purity in HPLC" is queried by researchers. A robust supplier CoA will state: the purity method and detection wavelength; the acceptance threshold applied (for example, single largest impurity and total impurities limits); and whether LC-MS was used for impurity identification. Cross-check the reported purity against any independent incoming testing you perform, and confirm that the impurity limits on the CoA match the specification the supplier claims to release against. Consistency between the specification, the reported results and the physical lot is the point of the exercise — not the size of the purity number alone.
Why do counterion and water content change the true Epithalon content?
A frequently overlooked part of supplier evaluation is that the mass in the vial is not all peptide. Synthetic peptides purified by reversed-phase HPLC are typically isolated as salts — most often trifluoroacetate (TFA) or acetate — and they also carry residual and hygroscopically absorbed water. Both reduce the net peptide content below the gross weighed mass, which is why two suppliers can list the same milligram figure yet deliver different amounts of actual AEDG. A rigorous CoA therefore reports counterion identity and level (by ion chromatography or a suitable quantitative method) and water content (commonly by Karl Fischer titration), then derives a net peptide content, sometimes via amino acid analysis. For quantitative research this net-content correction is essential to preparing accurate concentrations, and it is a strong marker of a technically serious supplier. When comparing Australian vendors, check whether the CoA states: the counterion present (TFA versus acetate); the residual water percentage; and a net peptide content or salt-corrected content value. If only gross mass and purity are given, the true amount of tetrapeptide is unknown. Note that TFA and acetate behave differently in downstream buffer systems and detection, so knowing the salt form also supports method reproducibility in your own laboratory. None of these parameters relate to human use; they exist so that an analyst can weigh, reconstitute and quantify the reagent correctly and reconcile mass balance against the reported purity. A supplier who can explain their counterion and water-content methodology on request is demonstrably operating a real quality system.
What stability and storage data indicate a well-characterised lot?
Stability data tells you how a lot is expected to behave between dispatch and use, and a considered supplier will document it rather than leave it implied. For a tetrapeptide, the relevant degradation pathways to understand include hydrolysis, deamidation of the glutamate and aspartate residues, and physical changes such as moisture uptake in the lyophilised solid. Well-run suppliers provide storage recommendations for the dry, lyophilised material and may reference forced-degradation or freeze-thaw study designs that characterise how the peptide changes under stress — data that supports the assignment of a retest date. Because Epithalon has been studied in cell-based research contexts (Al-Dulaimi et al., 2025; Ullah et al., 2025), analysts working with it will want confidence that the reconstituted material they characterise matches the released lot, which makes reconstitution guidance and solution-stability notes valuable. When assessing a supplier, look for: recommended storage conditions for the lyophilised solid; a stated retest or re-evaluation date tied to the lot; and any reference to stability-indicating methods (HPLC able to resolve degradation products from the main peak). Rather than temperature-controlled shipping, which we do not offer, the practical Australian advantage is local warehouse stock with tracked dispatch, so transit times are short and the lot documentation travels with the order. Ask whether the CoA and stability information are lot-specific and downloadable. Stability documentation, like every other item here, is analytical and QC information only — it describes the physical and chemical behaviour of the reagent, never any biological effect or use in living subjects.
How do you verify batch traceability before you buy?
Traceability is what connects a specific vial in your hand to the testing that released it, and it is the final checkpoint of supplier evaluation. A traceable supply chain means every vial carries a lot or batch number that maps to a single CoA, and that CoA is retrievable on request or via a lookup, not a generic PDF reused across unrelated lots. For bulk or multi-vial orders, a competent supplier provides a consolidated batch report so that per-vial consistency within a shared lot can be demonstrated. Before purchase, run this short verification sequence: request the CoA for the exact lot you will receive; confirm the lot number, product name and stated sequence match across the label, the CoA header and the specification; check that the identity method, purity method and net-content parameters discussed above are all present; and confirm the document is dated and attributable to a named testing arrangement. If a vendor cannot produce a lot-matched CoA before you pay, the material is effectively uncharacterised regardless of the price. Australian buyers benefit from local stock with tracked dispatch and per-lot documentation because it keeps the paper trail intact from warehouse to bench. Keep the CoA on file alongside your own incoming-goods results so that any future query about the material can be reconciled against release data. This documentation discipline is standard research quality-systems practice and is entirely independent of any application of the peptide — it exists so the reagent's identity and quality can be defended on the record.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
What is Epithalon and how is it written?
Epithalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It is also spelled Epitalon in the literature and is described as a short pineal-derived regulatory peptide (Araj et al., 2025). ClaraScience supplies it strictly as a research reagent characterised by analytical methods, not for human or animal use.
How can I verify an Epithalon CoA is genuine?
Match the lot number, product name and stated AEDG sequence across the vial label and the CoA, then confirm the document names an identity method (mass spectrometry), a purity method (HPLC with wavelength) and net-content parameters such as counterion and water content. A lot-specific, dated CoA that can be produced before purchase is the key indicator.
Why is net peptide content different from the labelled mass?
Synthetic peptides are isolated as salts (often TFA or acetate) and carry residual water, so part of the weighed mass is not peptide. A rigorous CoA reports counterion level and Karl Fischer water content, then derives net peptide content, letting you weigh and quantify the reagent accurately.
What analytical methods confirm Epithalon identity?
Orthogonal methods are used: ESI-MS or MALDI-TOF for molecular mass against the theoretical AEDG value, tandem MS/MS for sequence-level confirmation, and reversed-phase HPLC retention time against a qualified reference standard. No single result alone is treated as proof of identity.
Does ClaraScience offer temperature-controlled shipping for Epithalon?
No. Rather than cold-chain transport, our Australian advantage is local warehouse stock with tracked dispatch, so transit times are short and lot-specific analytical documentation travels with each order. Storage recommendations for the lyophilised solid are provided on the documentation.
References
- PMID:40141333 — Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — Int J Mol Sci — 2025
- PMID:14666197 — Effect of regulatory peptides on gene transcription — Bull Exp Biol Med — 2003
- PMID:15990728 — DNA double-helix binds regulatory peptides similarly to transcription factors — Neuro Endocrinol Lett — 2005
- PMID:40908429 — Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — Biogerontology — 2025
- PMID:39788414 — Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development — Life Sci — 2025
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
